BRIEF published on 08/10/2026 at 07:35, 2 months 28 days ago Nicox's NCX 470 NDA Submitted in China Nicox Glaucoma Treatment NCX 470 Ocumension China NDA
PRESS RELEASE published on 08/10/2026 at 07:30, 2 months 28 days ago Nicox Announces NCX 470 NDA Submission in China by Partner Ocumension Nicox's partner Ocumension submits NCX 470 NDA for lowering IOP in China, mirroring recent U.S. submission. Approval expected in 12-18 months Nicox NCX 470 Ocumension NDA Submission IOP Lowering
BRIEF published on 07/01/2026 at 07:35, 4 months 6 days ago Nicox: NDA submitted for NCX 470 in the United States FDA Glaucoma Nicox NCX 470 Kowa
BRIEF published on 06/23/2026 at 07:35, 4 months 14 days ago Nicox and Vester Finance: Partnership to Support Strategic Initiatives Funding New Actions Nicox NCX 470 Vester Finance
BRIEF published on 06/23/2026 at 07:35, 4 months 14 days ago Nicox and Vester Finance Enter Strategic Shareholder Loan Agreement Strategic Flexibility Nicox Shareholder Loan NCX 470 Vester Finance
PRESS RELEASE published on 06/23/2026 at 07:30, 4 months 14 days ago Nicox and Vester Finance Sign Shareholder Loan Agreement to Support Strategic Activities for the Company Nicox and Vester Finance sign a €6.0 million shareholder loan agreement to support strategic activities, providing flexibility for future opportunities Financial Agreement Nicox Shareholder Loan Vester Finance Strategic Activities
BRIEF published on 06/18/2026 at 07:35, 4 months 19 days ago Nicox Receives Positive Feedback for NCX 470 in China Ophthalmology Nicox NCX 470 Regulatory Feedback NDA China
PRESS RELEASE published on 06/18/2026 at 07:30, 4 months 19 days ago Nicox Announces Positive Pre-submission Regulatory Feedback in China Supporting NDA filing for NCX 470 Nicox's licensee in China, Ocumension, receives positive regulatory feedback for NCX 470, advancing towards NDA filing. Global milestones set for NCX 470 submissions Nicox NCX 470 Ocumension NDA Filing Regulatory Feedback
BRIEF published on 06/08/2026 at 07:35, 4 months 29 days ago Nicox warrants expiring soon in June 2024 Euronext Stock Trading Ophthalmology Nicox BSA Expiration
BRIEF published on 06/08/2026 at 07:35, 4 months 29 days ago Nicox Reminds Investors of June 2024 Warrants Expiration Warrants Stock Market Nicox Expiration Sophia Antipolis
Published on 11/06/2026 at 22:15, 10 hours 38 minutes ago Jaguar Health Reports Approval of All Proposals at November 2026 Special Meeting of Stockholders
Published on 11/06/2026 at 13:00, 19 hours 53 minutes ago Alaska Energy Metals Achieves High Extraction Rates of Metals from Hydromet Testing, Nikolai Nickel Project, Alaska
Published on 11/06/2026 at 12:30, 20 hours 23 minutes ago Relevant Gold Receives Expanded Drilling Approvals for the Lewiston Project in Wyoming
Published on 11/06/2026 at 12:30, 20 hours 23 minutes ago Vogenx Reports Third Quarter 2026 Financial Results and Business Highlights
Published on 11/06/2026 at 20:15, 12 hours 38 minutes ago African Medicines Agency Marks First Year of Operations with New Platforms to Strengthen Regulation and Support Manufacturing
Published on 11/06/2026 at 19:15, 13 hours 38 minutes ago EQS-Adhoc: ABO Energy GmbH & Co. KGaA suspends the interest payment on the bond 2024/2029 due on 8 November 2026.
Published on 11/06/2026 at 19:00, 13 hours 53 minutes ago Finexity AG: FINEXITY issues 2026/2030 bond with a minimum of 7.00% p.a. – either conventionally in a securities account or as a crypto security in a wallet
Published on 11/06/2026 at 18:32, 14 hours 21 minutes ago EQS-Adhoc: Finexity AG: FINEXITY issues 2026/2030 bond
Published on 11/06/2026 at 18:00, 14 hours 53 minutes ago ARVERNE GROUP: Number shares and voting rights
Published on 11/06/2026 at 18:00, 14 hours 53 minutes ago DISCLOSURE OF SHARE CAPITAL AND VOTING RIGHTS
Published on 11/06/2026 at 17:54, 14 hours 59 minutes ago Disclosure of Share Capital and Voting Rights as of October 31, 2026
Published on 11/06/2026 at 17:35, 15 hours 18 minutes ago Disclosure of the number of shares and the total number of voting rights as of October 31, 2026
